These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 16198481
1. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis. Hofstetter HH, Toyka KV, Gold R. Neurosci Lett; 2006 Jan 02; 391(3):127-30. PubMed ID: 16198481 [Abstract] [Full Text] [Related]
2. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A. Ann Neurol; 2009 Sep 02; 66(3):390-402. PubMed ID: 19810097 [Abstract] [Full Text] [Related]
3. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. J Immunol; 1998 Oct 15; 161(8):4437-46. PubMed ID: 9780223 [Abstract] [Full Text] [Related]
4. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD. J Immunol; 1998 May 01; 160(9):4271-9. PubMed ID: 9574529 [Abstract] [Full Text] [Related]
5. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. van Stipdonk MJ, Willems AA, Verbeek R, Boog CJ, van Noort JM. Cell Immunol; 2000 Sep 15; 204(2):128-34. PubMed ID: 11069720 [Abstract] [Full Text] [Related]
6. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z. J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385 [Abstract] [Full Text] [Related]
7. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. J Immunol; 1995 Nov 15; 155(10):5003-10. PubMed ID: 7594507 [Abstract] [Full Text] [Related]
8. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis. Li O, Liu JQ, Zhang H, Zheng P, Liu Y, Bai XF. Scand J Immunol; 2006 Aug 15; 64(2):117-24. PubMed ID: 16867156 [Abstract] [Full Text] [Related]
9. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A. Int Immunol; 2008 Nov 15; 20(11):1439-49. PubMed ID: 18801757 [Abstract] [Full Text] [Related]
10. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis. Jensen MA, Arnason BG, Toscas A, Noronha A. J Autoimmun; 1996 Oct 15; 9(5):587-97. PubMed ID: 8933274 [Abstract] [Full Text] [Related]
11. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis]. Rodríguez-Rodríguez Y, Suárez-Luis I. Rev Neurol; 1996 Oct 15; 36(7):649-52. PubMed ID: 12666047 [Abstract] [Full Text] [Related]
13. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Miller SD, McMahon EJ, Schreiner B, Bailey SL. Ann N Y Acad Sci; 2007 Apr 15; 1103():179-91. PubMed ID: 17376826 [Abstract] [Full Text] [Related]